Reply

TY - JOUR

T1 - Reply

AU - HAWK and HARRIER Study Investigators

AU - Dugel, Pravin U.

AU - Koh, Adrian

AU - Ogura, Yuichiro

AU - Jaffe, Glenn J.

AU - Schmidt-Erfurth, Ursula

AU - Brown, David M.

AU - Gomes, Andre V.

AU - Warburton, James

AU - Weichselberger, Andreas

AU - Holz, Frank G.

N1 - Funding Information: G.J.: Research funds – Alcon/Novartis, during the conduct of this study; Consultant – Sanofi, Heidelberg Engineering, Novartis, pSivida, Regeneron, outside the submitted work. Financial Disclosures: The authors made the following disclosures: D.B.: Grant – Alcon, during the conduct of this study; Grants – Novartis, Regeneron, Santen, Ophthotech, Clearside Biomedical, Aerpio, Allergan, Samsung, Thrombogenics, Heidelberg, NEI, Chengdu Kanghong Biotech Co, Ltd, Adverum, Regenxbio, Allegro, OHR, Tyrogenix, outside the submitted work; Personal fees – Alcon, during the conduct of this study; Personal fees – Novartis, Regeneron, Bayer, Santen, Clearside Biomedical, Allergan, Samsung, Thrombogenics. Heidelberg, Optos, Chengdu Kanghong Biotechnology Co., Ltd, Adverum, Regenxbio, Google/Verily, Carl Zeiss Meditec, Coda Therapeutics, Janssen, Johnson & Johnson, OHR, Notal Vision, Optovue, Pfizer, Senju Pharmaceuticals, Stealth Biotherapeutics, Tyrogenix, outside the submitted work. F.H.: Grant – Alcon/Novartis, Heidelberg Engineering, Genentech/Roche, Allergan, Pixium, Nightstar, Optos, Carl Zeiss Meditech, during the conduct of this study; Personal fees – Alcon/Novartis, during the conduct of this study; Consulting – Heidelberg Engineering, Zeiss, Acucela, Genentech/Roche, Allergan, Boehringer-Ingelheim; Bayer Healthcare, LIN Bioscience, Pixium, Gallmedix, during the conduct of this study; Speakers bureau – Bayer Healthcare, Genentech/Roche, Zeiss, Heidelberg Engineering, outside the submitted work. Y.O.: Grant – Novartis Pharma, during the conduct of this study; Personal fees – Novartis Pharma, during the conduct of this study; Grant – Santen, outside the submitted work; Personal fees – Bayer, Santen, Senju, Kowa, Wakamoto, Hoya, outside the submitted work.

PY - 2019/12

Y1 - 2019/12

UR - http://www.scopus.com/inward/record.url?scp=85074786150&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85074786150&partnerID=8YFLogxK

U2 - 10.1016/j.ophtha.2019.08.016

DO - 10.1016/j.ophtha.2019.08.016

M3 - Letter

C2 - 31759510

AN - SCOPUS:85074786150

SN - 0161-6420

VL - 126

SP - e96-e97

JO - Ophthalmology

JF - Ophthalmology

IS - 12

ER -